| Similar Articles |
|---|
 |
BusinessWeek
May 24, 2004
Arlene Weintraub |
Regenerative Medicine's Slow Start Scientists think proteins that spur the body to heal could make powerful drugs, but harnessing that potential has been tough   |
Technology Research News
March 26, 2003 |
Plastic coating makes chips biofriendly Electronics usually don't mix well with biological material. Sandia National Laboratories researchers have overcome the incompatibility with a microscopic laser designed to quickly measure and identify microorganisms and cell types without inhibiting biological processes. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
The Motley Fool
October 27, 2010
Ralph Casale |
Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment. |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
Bio-IT World
February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
The Motley Fool
July 8, 2008
Brian Lawler |
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. |
BusinessWeek
May 24, 2004
Arlene Weintraub |
Repairing The Engines Of Life Can research into stem cells and other advanced techniques heal ailing hearts and brains? U.S. labs are hamstrung by the federal government. |
The Motley Fool
March 8, 2010
Brian Orelli |
Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting. |
Bio-IT World
February 18, 2004 |
Proteomics Goes Cellular Tissue microarrays save big on sample material and reagents. But more importantly, this new high-throughput technology is helping save the lives of cancer patients |
The Motley Fool
September 14, 2010
Luke Timmerman |
Arena Obesity Drug Effective by "Slim Margin"; Shares Tumble The market is reacting negatively to news about the company's weight-loss drug. |
InternetNews
June 8, 2004
Michael Singer |
New Pact on Sub-Micron Chip Standards Engineering bodies, IEEE and SEMI sign an agreement to support each other's efforts in the field of nanotechnology and MEMS. |
Chemistry World
October 2, 2013
Michael Parkin |
Insect-powered microtweezers Scientists in Japan have developed the first biohybrid microdevice that can function in air. The microtweezers powered by insect muscle tissue could be used to handle cells and other fragile objects as part of a microelectromechanical system. |
